%0 Journal Article
%T Cracking the NLRP3 code: Pioneering precision medicine for inflammation.
%A Weber ANR
%A Tortola MM
%A Kuemmerle-Deschner JB
%J J Exp Med
%V 221
%N 5
%D 2024 May 6
%M 38536100
%F 17.579
%R 10.1084/jem.20240221
%X Precisely diagnosing and effectively treating cryopyrin-associated periodic syndrome (CAPS), an inflammatory condition linked to gain-of-function NLRP3 inflammasome mutations, poses challenges. A novel classification approach may help inform therapeutic decisions and offer valuable insights into broader inflammatory conditions (Cosson et al. J. Exp. Med. 2024. https://doi.org/10.1084/jem.20231200).